The day before announcing Zyn’s marketing authorization, FDA Center for Tobacco Products announced another proposed rule that could have a massive impact on public health: a product standard that ...
By 2035, rising consumption of smokeless tobacco and nicotine products is expected to overtake shrinking demand for ...
I rate PM shares a "hold" due to optimistic current valuations and potential risks in the smokefree business, despite its ...
Reynolds American expects to add about 300 jobs in the U.S. in 2025, with a majority of those focused on its Velo Plus oral smokeless nicotine pouches, according to a statement from the tobacco ...
Philip Morris surged 66% in the past year, outperforming even Nvidia amidst a market shift towards quality investments. Read ...
"This product is distinguishable from other smokeless tobacco products because ... Last month, the FDA approved 10 flavors of Philip Morris International’s Zyn brand of nicotine pouches ...
It's rare to find a growth stock in a defensive industry such as tobacco, but that is exactly what Philip Morris International (NYSE: PM) has become. The company's smokeless portfolio has helped ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results